Finance
Beta
search
Search or ask
settings
Theme
mobile
Device default
âś“
dark_mode
Dark theme
light_mode
Light theme
Search labs
feedback
Send feedback
Sign in
Lists
playlist_add
New
CANC
Research
CANC:NASDAQ
check_indeterminate_small
Tema Oncology ETF
$40.85
arrow_upward
+0.85%
(
+0.34
) 1D
Jul 17, 3:38:37 PM GMT-4 · USD
area_chart
Area
stacked_line_chart
Compare
search
close
All symbols
monitoring
Indicators
No data
1D
5D
1M
6M
YTD
1Y
5Y
MAX
Symbol
Price
Change
% Change
Overview
insights_auto
Generating top insights for CANC...
Open
$40.25
High
$41.27
Low
$39.93
Avg. vol.
43.69K
Volume
8.47K
52-wk high
$42.63
52-wk low
$25.12
Open
$40.25
High
$41.27
Low
$39.93
Avg. vol.
43.69K
Volume
8.47K
52-wk high
$42.63
52-wk low
$25.12
Related assets
SBIO
ALPS Medical Breakthroughs ETF
$65.13
+3.00%
arrow_upward
XBI
State Street SPDR S&P Biotech ETF
$154.43
+1.60%
arrow_upward
IBB
iShares Biotechnology ETF
$189.69
+0.09%
arrow_upward
FBT
First Trust NYSE Arca Biotechnology Index Fund
$247.74
-0.62%
arrow_downward
News stories
From sources across the web
Simply Wall Street
·
12 minutes ago
Nebius Group (NBIS) Raised $775 Million To Speed Up Its AI Cloud Buildout
The Motley Fool
·
3 minutes ago
Apple Had the Cash to Buy Any of 486 S&P 500 Companies, but Tim Cook Bet $851 Billion on This Instead
Yahoo Finance
·
1 hour ago
Cboe Global vs. Nasdaq: Which Exchange Stock Is the Better Buy Now?
CNBC
·
8 hours ago
Obscure volatility measure points to a 'Magnificent Seven’ earnings breakout
Show more
AI content may include mistakes.
Learn more
Help
Send feedback
Privacy
Terms
Disclaimer
Research
edit_square
New thread
notes_spark
Thread history
close
Collapse
expand_content
Expand
What's on your mind?
What's going on with the markets today?
search_spark
Explore what’s possible
add
Create a portfolio
task_spark
Create a task
travel_explore
Deep Search
mic
Voice Search
add
Add Tool
upload_file
Upload File
bar_chart
Create portfolio
travel_explore
Deep Search
arrow_upward
Ask AI
search_spark
mic
Voice Search
AI content may include mistakes.
Learn more
Help
Send feedback
Privacy
Terms
Disclaimer